Viral Shedding Dynamics in COVID-19 Patients

The dynamics of viral shedding in COVID-19 patients describe how and when SARS-CoV-2 is released from the human body and become detectable by molecular assays. Shedding typically peaks around the time of symptom onset in the upper respiratory tract and declines over subsequent days to weeks, although RNA fragments may persist for extended periods. Factors such as age, disease severity, host immune status and viral variant influence both the duration and magnitude of shedding. Immunocompromised individuals and those with severe illness often exhibit prolonged or intermittent shedding, sometimes exceeding four weeks. Variant-specific traits have also emerged; for example, the Omicron lineage is associated with high early viral loads but somewhat shorter median shedding times in vaccinated populations. Understanding these patterns is critical for guiding isolation periods, informing treatment decisions and shaping public-health measures to limit onward transmission. Global studies have examined respiratory, faecal and, less commonly, ocular samples, revealing that extra-respiratory shedding may occur but its epidemiological relevance remains lower than that of respiratory secretions. Overall, the integration of clinical, immunological and virological data has provided a nuanced picture of how SARS-CoV-2 is released, controlled and cleared from the human body.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Viral Shedding Dynamics in COVID-19 Patients publication trend

The graph below shows the total number of articles in viral shedding dynamics in covid-19 patients across all publications each year (not limited to Nature Index journals).

Technical terms

Viral shedding: Release of virus particles from an infected individual into the environment or bodily fluids.

RT-PCR: Reverse transcription polymerase chain reaction, a laboratory method for detecting viral RNA.

Cycle threshold (Ct) value: The number of amplification cycles in RT-PCR required to detect viral RNA; inversely related to viral load.

Viral clearance: The time point at which viral RNA is no longer detectable in serial tests.

Intermittent shedding: Non-continuous detection of viral RNA after an initial negative result, leading to alternating positive and negative tests.

References

1. Clinical analysis of prolonged viral clearance time in patients with lymphoma combined with novel coronavirus infection. Frontiers in Molecular Biosciences (2023).
2. Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2. Frontiers in Public Health (2023).
3. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection. Clinical & Translational Immunology (2020).
4. Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study. BMC Infectious Diseases (2021).
5. Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: a population-based prospective cohort study in Reggio Emilia, Italy. BMJ Open (2020).